Search Results - "Belardi, Jorge"

Refine Results
  1. 1

    TAVR prosthesis recoil: Unknowns and implications by Belardi, Jorge A., Lamelas, Pablo

    “…Key Points TAVR acute recoil has not been properly assessed with current generation balloon‐expandable prosthesis. Acute recoil was greater during initial…”
    Get full text
    Journal Article
  2. 2

    The PROGRESS‐CTO perforation risk score. Are you in? by Belardi, Jorge A., Lamelas, Pablo M.

    “…Key Points Coronary perforation is a life‐threatening complication of chronic total occlusion angioplasty. In a large assessment, the PROGRESS‐CTO perforation…”
    Get full text
    Journal Article
  3. 3

    How to set up regional STEMI networks: a "Stent - Save a life!" initiative by Candiello, Alfonsina, Alexander, Thomas, Delport, Rhena, Toth, Gabor G, Ong, Paul, Snyders, Adriaan, Belardi, Jorge A, Lee, Michael K Y, Pereira, Helder, Mohamed, Awad, Mayol, Jorge, Piek, Jan J, Wijns, William, Baumbach, Andreas, Naber, Christoph

    Published in EuroIntervention (18-03-2022)
    “…Clinical guidelines recommend the development of ST-elevation myocardial infarction (STEMI) networks at community, regional and/or national level to ideally…”
    Get full text
    Journal Article
  4. 4

    Gender and left atrial appendage occlusion: Not the exception in cardiovascular procedures by Belardi, Jorge A., Lamelas, Pablo M.

    “…Key Points Gender disparities have been described in many cardiovascular procedures, but reports about left atrial appendage occlusion are limited. In a large…”
    Get full text
    Journal Article
  5. 5

    New TAVR item added to cart for large scale clinical testing by Belardi, Jorge A., Lamelas, Pablo M.

    “…Key Points There is no single TAVR prosthesis that can be considered ideal for all patients, needing the development of newer technologies. The GENESIS trial…”
    Get full text
    Journal Article
  6. 6

    Impella support for chronic total occlusions angioplasty: A good start by Belardi, Jorge A., Lamelas, Pablo

    “…Key Points There is limited data regarding percutaneous ventricular support in chronic total occlusion angioplasty in terms of population, procedure, and…”
    Get full text
    Journal Article
  7. 7

    Contemporary stents: Tough to get better by Belardi, Jorge A., Lamelas, Pablo M.

    “…Key Points Bioabsorbable drug eluting‐stents have been tested in randomized trials, typically excluding complex coronary procedures. In a large study,…”
    Get full text
    Journal Article
  8. 8

    Retrograde approach for chronic total occlusion angioplasty: At your own risk by Belardi, Jorge A., Lamelas, Pablo M.

    “…Key Points The retrograde approach is needed to increase procedural success in chronic total occlusion angioplasty. This systematic review of the literature…”
    Get full text
    Journal Article
  9. 9

    Onyx is the new black by Belardi, Jorge A., Albertal, Mariano

    “…Key Points Ultrathin drug‐eluting stent (DES) constitute the workhorse stent for routine percutaneous coronary interventions. The Resolute Onyx is a novel…”
    Get full text
    Journal Article
  10. 10

    Gender disparities in high‐risk angioplasty: Still room for improvement by Belardi, Jorge A., Lamelas, Pablo M.

    “…Key Points The use of complex medical interventions is frequently underutilized in females. Female patients undergoing high‐risk angioplasty with ventricular…”
    Get full text
    Journal Article
  11. 11

    Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation by Silber, Sigmund, Kirtane, Ajay J, Belardi, Jorge A, Liu, Minglei, Brar, Sandeep, Rothman, Martin, Windecker, Stephan

    Published in European heart journal (01-08-2014)
    “…The optimal duration of dual antiplatelet therapy (DAPT) following the use of new generation drug-eluting stents is unknown. The association between DAPT…”
    Get full text
    Journal Article
  12. 12

    Anticoagulation with heparin The art of simplicity even in patients on dialysis by Belardi, Jorge A., Albertal, Mariano

    “…Key Points In current PCI practice, anticoagulation with either bivalirudin or unfractionated heparin in patients with ACS share comparable efficacy and…”
    Get full text
    Journal Article
  13. 13

    Direct stenting versus balloon predilation: Jury is still out by Belardi, Jorge A., Albertal, Mariano

    “…Key Points Compared to balloon predilation, direct stenting (DS) shortens procedural time and reduces radiation and contrast exposure. A meta-analysis that…”
    Get full text
    Journal Article
  14. 14

    Percutaneous coronary interventions in diabetics: The never‐ending challenge by Belardi, Jorge A., Candiello, Alfonsina

    “…Key Points Diabetes mellitus (DM) is a multisystem disorder and a recognized risk factor for coronary artery disease (CAD) and DM patient are particularly…”
    Get full text
    Journal Article
  15. 15

    Predicting Early Readmission Following PCI: A Work in Progress by Belardi, Jorge A., Albertal, Mariano

    “…Key Points Early hospital readmissions after percutaneous coronary interventions (PCI) are common and costly. From the NCDR CathPCI Registry and the Centers…”
    Get full text
    Journal Article
  16. 16

    Overlapping bioresorbable scaffolds seems safe for now by Belardi, Jorge A., Albertal, Mariano

    “…Key Points Overlapping permanent scaffolds carries a long‐term risk of target vessel failure due to late malapposition and the development of…”
    Get full text
    Journal Article
  17. 17

    Transradial access: A case for knowledge translation by Belardi, Jorge A., Lamelas, Pablo M.

    “…Key Points Current transradial access (TRA) practices are unknown in the United States and the rest of the world. There is a decline in preprocedure collateral…”
    Get full text
    Journal Article
  18. 18

    Non‐cardiac surgery after PCI: Watch out for complex lesions by Belardi, Jorge A., Albertal, Mariano

    “…Key Points Patients who undergo non‐cardiac surgery after percutaneous coronary interventions (PCI) carry a risk of major adverse cardiac events. Certain…”
    Get full text
    Journal Article
  19. 19

    Transcatheter aortic valve replacement hemodynamic durability: Still in question? by Belardi, Jorge A., Lamelas, Pablo M.

    “…Key Points This study shows excellent transcatheter aortic valve replacement hemodynamic mid‐term durability, aligned with prior research up to 5‐years…”
    Get full text
    Journal Article
  20. 20

    Double‐stenting in distal left main lesions: Let's crush by Belardi, Jorge A., Albertal, Mariano

    “…Key Points Unprotected distal left main (ULM) lesions often require double‐stenting. In the MITO Registry, a mini‐crush stenting technique was safer than…”
    Get full text
    Journal Article